Table 1 Resource use for SQ HDM SLIT-tablet and HDM SCIT (Ontario and Quebec)

10 mL vial^a (10 inj.)

–

–

–

3.1

1.3

1.3

–

–

–

3.1

1.3

1.3

SQ HDM SLIT-tablet (package with 30 tablets)

12

12

12

–

–

–

12

12

12

–

–

–

Start-up visits

1

–

–

–

–

–

1

–

–

1

–

–

 GP (Ontario 20%, Quebec 5%)^a

0.2

–

–

–

–

–

0.05

–

–

0.05

–

–

 Specialist (Ontario 80%, Quebec 95%)^a

0.8

–

–

–

–

–

0.95

–

–

0.95

–

–

Titration visits (1 week between inj. [15])

–

–

–

24

–

–

–

–

–

24

–

–

 GP (Ontario 20%, Quebec 95%)^a

–

–

–

4.8

–

–

–

–

–

22.8

–

–

 Specialist (Ontario 80%, Quebec 5%)^a

–

–

–

19.2

–

–

–

–

–

1.2

–

–

Maintenance visits (4 weeks between inj. [15])

–

–

–

7

13

13

–

–

–

7

13

13

 GP (95%)^a

–

–

–

6.65

12.35

12.35

–

–

–

6.65

12.35

12.35

 Specialist (5%)^a

–

–

–

0.35

0.65

0.65

–

–

–

0.35

0.65

0.65

Nurse time ([h]; Ontario 0.5 per inj., Quebec 0.75 per inj.)^a

–

–

–

15.5

6.5

6.5

–

–

–

23.25

9.75

9.75

Nurse time ([h]; 0.75 per start-up, tablet/only Quebec)

–

–

–

–

–

–

0.75

–

–

–

–

–

Follow-up visits

1

1

1

1

1

1

1

1

1

1

1

1

 GP (Ontario 50% SLIT, 20% SCIT; Quebec 50%)^a

0.5

0.5

0.5

0.2

0.2

0.2

0.5

0.5

0.5

0.5

0.5

0.5

 Specialist (Ontario 50% SLIT, 80% SCIT; Quebec 50%)^a

0.5

0.5

0.5

0.8

0.8

0.8

0.5

0.5

0.5

0.5

0.5

0.5

Patient’s time [h]^a [15]

3^c

1.25^c

1.25^c

57.57^b

24.87^b

24.87^b

3^c

1.25^c

1.25^c

48.48^b

20.53^b

20.53^b

Patient’s travel distance ([km]; 20 km per visit) [15]

40

20

20

620

260

260

40

20

20

660

280

280